glp 1 vs sglt2 GLP-1 for CKD: Which Is Better? Renal outcomes of SGLT2 inhibitors
Description
Two cases involved cholelithiasis, and two patients received treatment with either empagliflozin or sitagliptin, which could potentially contribute to or confound pancreatitis
A new prescription approved by the U.S
Growth Opportunity Analysis 2.1.4
Compounding also allows dosing flexibility, which supports gradual titration and longer-term use
Both in clinical studies and real-world studies, combined use is associated with better glycemic control
Weekly averages matter more than daily fluctuations
